Exane Derivatives’s AB InBev BUD Stock Holding History

Exane Derivatives’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-905	Closed	-$72	–	707
2019 Q4	$72	Buy	905 +52	+6%	+$4.33K	﹤0.01%	662
2019 Q3	$63.2K	Buy	853 +850	+28,333%	+$80.7K	0.01%	353
2019 Q2	$1.3K	Sell	3 -47	-94%	-$4.03K	﹤0.01%	544
2019 Q1	$6.58K	Sell	50 -393	-89%	-$30.2K	﹤0.01%	408
2018 Q4	$726K	Sell	443 -910	-67%	-$69.6K	0.13%	145
2018 Q3	$1.5K	Sell	1,353 -151	-10%	-$14.7K	﹤0.01%	512
2018 Q2	$381K	Buy	1,504 +1,054	+234%	+$105K	0.06%	196
2018 Q1	$4.05K	Sell	450 -1,220	-73%	-$135K	﹤0.01%	434
2017 Q4	$191K	Buy	1,670 +761	+84%	+$89.5K	0.03%	242
2017 Q3	$553K	Buy	909 +228	+33%	+$26.7K	0.1%	129
2017 Q2	$48K	Buy	681 +380	+126%	+$43.5K	0.01%	319
2017 Q1	$3.39K	Sell	301 -1,225	-80%	-$132K	﹤0.01%	385
2016 Q4	$101K	Buy	1,526 +419	+38%	+$47K	0.02%	249
2016 Q3	$437K	Buy	+1,107	New	+$140K	0.07%	162
2016 Q2	–	Sell	-283	Closed	-$88.2K	–	562
2016 Q1	$88.2K	Buy	283 +202	+249%	+$24K	0.01%	256
2015 Q4	$18.2K	Buy	+81	New	+$9.8K	﹤0.01%	302

Other funds holding BUD

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BCF

BLS Capital Fondsmaeglerselskab Klampenborg, Denmark $2.94B AUM 13.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Exane Derivatives's BUD Position: Q2 2022 in Review

Exane Derivatives held its AB InBev (BUD) position steady in Q2 2022 at 6 shares worth $324. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Exane Derivatives first reported a position in BUD in Q3 2015 and has held it in 23 quarters since. The position peaked at $11.3M in Q4 2016. 513 funds tracked by Wall St. Rank hold BUD as of Q2 2022.

Exane Derivatives held 6 shares of AB InBev worth $324 as of Q2 2022.
Exane Derivatives left its AB InBev share count unchanged in Q2 2022.
AB InBev made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #626 holding.
Exane Derivatives first reported a position in AB InBev in Q3 2015 and has held it in 23 quarters since.
Exane Derivatives's AB InBev position peaked at $11.3M in Q4 2016.
513 funds tracked by Wall St. Rank held AB InBev as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.